Identifai Genetics LimitedASX: ID1

ID1 advances US prenatal screening after $10m IPO

Oct 12, 2026 at 5:13 PM EDT · Issued by Identifai Genetics Limited via ASX

Filed with ASX · Oct 12, 2026 at 5:13 PM EDT

On 6ix: 6ix.com/news/id1-advances-us-prenatal-screening-after-dollar10m-ipo

13 October 2026 Identifai Genetics lists on the ASX following a $10 million IPO to advance US prenatal screening strategy IPO funding to advance clinical validation and US laboratory readiness for Windrose™, a prenatal genetic screening platform designed to assess selected inherited...

View Attachment

6ix hasn’t read this filing yet.

Identifai Genetics Limited on 6ix

In the deck

Identifai Genetics — IPO Roadshow (October 2026)35 slidesOct 14, 2026

Earlier from Identifai Genetics

Pre-quotation Disclosure AnnouncementOct 8
Top 20 HoldersOct 8
Distribution ScheduleOct 8
Securities Trading PolicyOct 8
Employee Securities Incentive Plan (incl. Israeli Annexure)Oct 8

Later from Identifai Genetics

Interim ReportOct 12
Initial Director's Interest Notice x 4Oct 13
Becoming a substantial holderOct 13
IPO Investor PresentationOct 13

All Identifai Genetics news releases

Follow Identifai Genetics into a list and get an email when it puts out news.

Follow Identifai Genetics